A comparative study on the physicochemical properties and gastrointestinal delivery of calcium niosomes produced by low and high-energy techniques

Q2 Pharmacology, Toxicology and Pharmaceutics
Jorge Alejandro Barbosa-Nuñez , Sara Elisa Herrera-Rodríguez , Eristeo García-Márquez , Hugo Espinosa-Andrews
{"title":"A comparative study on the physicochemical properties and gastrointestinal delivery of calcium niosomes produced by low and high-energy techniques","authors":"Jorge Alejandro Barbosa-Nuñez ,&nbsp;Sara Elisa Herrera-Rodríguez ,&nbsp;Eristeo García-Márquez ,&nbsp;Hugo Espinosa-Andrews","doi":"10.1016/j.onano.2024.100205","DOIUrl":null,"url":null,"abstract":"<div><p>Since the bioavailability of calcium from foods and supplements is low, its encapsulation in niosomes is proposed as a potential solution to this issue. This study aimed to compare the physiochemical properties and release profiles of niosomes with calcium chloride and calcium lactate produced by injection and sonication methods. The size distribution (200–300 nm), encapsulation efficiency (20–40 %), stability, release profile, cytotoxicity, and calcium bioavailability of the niosomes were characterized. The production method, rather than the calcium salt used, impacted the properties of the niosomes. Calcium release under gastrointestinal conditions was dependent on both the calcium source and the production method, which was characterized by a Peppas-Sahlin release model. Calcium niosomes were not cytotoxic to intestinal cells. All the calcium niosomes showed high bioavailability in cells (5–20 % greater than the control) but lower bioavailability than the non-encapsulated calcium salts (80–110 % above control) due to their high solubility. Nevertheless, the use of niosomes might be a promising approach for improving calcium bioavailability.</p></div>","PeriodicalId":37785,"journal":{"name":"OpenNano","volume":"17 ","pages":"Article 100205"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352952024000069/pdfft?md5=e1988301879094919cc6233f1db3218c&pid=1-s2.0-S2352952024000069-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OpenNano","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352952024000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Since the bioavailability of calcium from foods and supplements is low, its encapsulation in niosomes is proposed as a potential solution to this issue. This study aimed to compare the physiochemical properties and release profiles of niosomes with calcium chloride and calcium lactate produced by injection and sonication methods. The size distribution (200–300 nm), encapsulation efficiency (20–40 %), stability, release profile, cytotoxicity, and calcium bioavailability of the niosomes were characterized. The production method, rather than the calcium salt used, impacted the properties of the niosomes. Calcium release under gastrointestinal conditions was dependent on both the calcium source and the production method, which was characterized by a Peppas-Sahlin release model. Calcium niosomes were not cytotoxic to intestinal cells. All the calcium niosomes showed high bioavailability in cells (5–20 % greater than the control) but lower bioavailability than the non-encapsulated calcium salts (80–110 % above control) due to their high solubility. Nevertheless, the use of niosomes might be a promising approach for improving calcium bioavailability.

低能量和高能量技术制备的钙离子口服液的理化性质和胃肠道给药比较研究
由于食物和补充剂中钙的生物利用率较低,因此将钙封装在niosomes中被认为是解决这一问题的潜在方法。本研究旨在比较用注射法和超声法生产的含氯化钙和乳酸钙的niosomes的理化性质和释放曲线。研究表征了niosomes的尺寸分布(200-300 nm)、封装效率(20-40 %)、稳定性、释放曲线、细胞毒性和钙的生物利用率。生产方法而不是所使用的钙盐影响了niosomes的特性。钙在胃肠道条件下的释放既取决于钙源,也取决于生产方法。钙诺糖对肠道细胞没有细胞毒性。所有钙诺沙姆斯在细胞中的生物利用率都很高(比对照组高 5-20%),但由于其溶解度高,生物利用率低于非胶囊钙盐(比对照组高 80-110%)。尽管如此,使用niosomes可能是提高钙生物利用率的一种有前途的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
OpenNano
OpenNano Medicine-Pharmacology (medical)
CiteScore
4.10
自引率
0.00%
发文量
63
审稿时长
50 days
期刊介绍: OpenNano is an internationally peer-reviewed and open access journal publishing high-quality review articles and original research papers on the burgeoning area of nanopharmaceutics and nanosized delivery systems for drugs, genes, and imaging agents. The Journal publishes basic, translational and clinical research as well as methodological papers and aims to bring together chemists, biochemists, cell biologists, material scientists, pharmaceutical scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信